Senior insider sale
Chief Operating Officer at ESPERION THERAPEUTICS, INC. — senior position signals high conviction
$238.6K
79.17K shares
What this filing means
KOENIG SHELDON L. plans to sell 79.17K shares of ESPERION THERAPEUTICS, INC. valued at approximately $238.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001959173-26-004750
Officer· Chief Operating Officer
Since Dec 2020
79.17K
Shares to sell
$238.6K
Approx. market value
53.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/16/2026
53.59KTotal acquired53.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/16/2026 | Restricted Stock Vesting Compensation | 53.59K | — |
| Total | 53.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25.58K
Market value
$69.6K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
53.59K
Market value
$169.1K
6/17/2026
Total
Units
79.17K
Value
$238.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 25.58K | $69.6K | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 53.59K | $169.1K | NASDAQ | Planned |
| Total | 79.17K | $238.6K | ||